CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro

Journal of Rheumatology

Volumn 26, Issue 2, 1999, Pages 294-301

  Sato, Yoshihiro ^a   Miyata, Masayuki ^a   Sato, Yukio ^a   Nishimaki, Tomoe ^a   Kochi, Hideo ^a   Kasukawa, Reiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CpG; Deoxyribonucleic acid; Systemic Lupus Erythematosus

Indexed keywords

CYTOSINE; DNA FRAGMENT; GAMMA INTERFERON; GUANINE; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; MESSENGER RNA; OLIGONUCLEOTIDE;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; HUMAN; HUMAN CELL; MOLECULAR CLONING; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; CPG ISLANDS; DNA; FATTY ACIDS, MONOUNSATURATED; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; QUATERNARY AMMONIUM COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032932445     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Tan EM. Autoantibodies to nuclear antigens: their immunology and medicine. Adv Immunol 1982;33:167-240.
2. Sano H, Imokawa M, Steinberg AD, Morimoto C. Accumulation of guanine-cytosine-enriched low MW DNA fragments in lymphocytes of patients with systemic lupus erythematosus. J Immunol 1983;130:187-90.
3. Sano H, Takai O, Harata N, Yoshinaga K, Kodama I, Sasaki T. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand J Immunol 1989;30:51-63.
4. Tokunaga T, Yamamoto H, Shimada S, et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984;72:955-62.
5. Shimada S, Yano O, Inoue H, et al. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J Natl Cancer Inst 1985;74:681-8.
6. Shimada S, Yano O, Tokunaga T. In vivo augmentation of natural killer cell activity with deoxynucleic acid fraction of BCG. Jpn J Cancer Res 1986;77:808-16.
7. Mashiba H, Matsunaga K, Tomoda H, Furusawa M, Jimi S, Tokunaga T. In vitro augmentation of NK activity of peripheral blood cells from cancer patients by a DNA fraction from M. bovis BCG. Jpn J Med Sci Biol 1988;41:197-202.
8. Yamamoto S, Kuramoto E, Shimada S, Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-α/ß and γ with deoxynucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988;79:866-73.
9. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN-mediated natural killer activity. J Immunol 1992;148:4072-6.
10. Yamamoto T, Yamamoto S, Kataoka T, Tokunaga T. Lipofection of synthetic oligonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol Immunol 1994;38:831-6.
11. Krieg AM, Ae-Kyung Y, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9.
12. Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (US) 1996;273:352-4.
13. Belmond HM, Buyon J, Giorno R, Abramson S. Upregulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum 1994;37:376-83.
14. Basham TY, Merigan TC. Recombinant interferon-γ increases HLA-DR synthesis and expression. J Immunol 1982;130:1492-4.
15. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by FL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Masi AT, Rodman GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
18. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
20. Digeon M, Laver M, Riza J, Bach JF. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. J Immunol Methods 1977;16:154-65.
21. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
22. 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 1987;139:3132-8.
23. Kogure A, Miyata M, Nishimaki T, Kasukawa R. Proliferative response of synovial fluid mononuclear cells of patients with rheumatoid arthritis to mycobacterial 65 kDa heat shock protein and its association with HLA-DR+ •γδ+ T cells. J Rheumatol 1994;21:1403-8.
24. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989;86:8941-5.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
26. Compton LJ, Steinberg AD, Sano H. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus. J Immunol 1984;133:213-6.
27. Elmen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
28. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
29. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus: occurrence as multimeric complexes bound to histone. J Clin Invest 1990;86:69-74.
30. Shapiro HS. Distribution of purines and pyrimidines in deoxyribonucleic acids. In: Fasman GD, editor. Handbook of biochemistry and molecular biology. Nucleic acids, vol. II. Cleveland, OH: CRC Press;1976:241-79.
31. Sano H, Morimoto C. DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J Immunol 1982;128:1341-5.
32. Emlem W, Ansari R, Burdick G. DNA-anti-DNA immune complexes: antibody protection of a discrete DNA fragment from DNase digestion in vitro. J Clin Invest 1984;74:185-90.
33. Wang AHJ, Quigley GJ, Kolpak FJ, van der Marel G, van Boom JH, Rich A. Left-handed double helical DNA: variations in the backbone conformation. Science 1981;211:171-6.
34. Selsing E, Wells RD, Alden CJ, Arnott S. Bent DNA: Visualization of a base-paired and attached A-B conformational junction. J Biol Chem 1979;254:5417-22.
35. Bird AP, Taggart M, Frommer M, Miller OJ, Macleod D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 1985;40:91-9.
36. Bird AP. CpG islands as gene markers in the vertebrate nucleus. Trends Genet 1987;3:342-7.
37. Setlow P. Nearest neighbor frequencies in deoxyribonucleic acids. In: Fasman GD, editor. Handbook of biochemistry and molecular biology. Nucleic acids, vol. II. Cleveland, OH: CRC Press;1976:312-8.
38. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209-13.
39. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990;33:1665-73.
40. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988; 140:2197-200.
41. Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS. Induction of anti-ds-DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 1989;142:1482-6.
42. Gilkeson GS, Pippen AMM, Pisetsky DS. Induction of cross-reactive anti-ds-DNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 1995; 95:1398-402.
43. Bird AP. CpG islands as gene markers in the vertebrate nucleus. Trends Genet 1987;3:342-7.
44. Cowdery JS, Chace JH, Yi-AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996;156:4570-5.
45. Halpern MD, Kurlander RJ, Lisetsky DS. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-γ. Cell Immunol 1996;167:72-8.
46. Hefeneider SH, McCoy SL, Morton JI, et al. DNA binding to mouse cells is mediated by cell-surface molecules: the role of these DNA-binding molecules as target antigens in murine lupus. Lupus 1992;1:167-7.3.
47. Loke SL, Stein CA, Zhang XH, et al. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 1989;86:3474-8.
48. Bennett RM, Gabor GT, Merritt MM. DNA binding to human leukocytes. J Clin Invest 1985;76:2182-90.